Clinical Trial Update: Urine NT-ProBNP in Neonatal Respiratory Distress

View source ↗

Summary

This update covers a clinical trial evaluating urine NT-ProBNP as a biomarker in neonates with neonatal respiratory distress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Snippet

Sponsor: Ankara University | Conditions: Neonatal Respiratory Distress | Status: UNKNOWN